Health & Fitness
Health and Fitness
Health and Fitness
Tue, February 21, 2012
Mon, February 20, 2012
Sat, February 18, 2012
Fri, February 17, 2012
Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield & Leveraged Finance Conference
Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield... -- CHADDS FORD, Pa., Feb. 17, 2012 /PRNewswire/ --
Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield & Leveraged Finance Conference
CHADDS FORD, Pa., Feb. 17, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: [ ENDP ]) today announced that Mark Gottlieb, vice president and treasurer, will present a corporate overview at the J.P. Morgan Annual Global High Yield & Leveraged Finance Conference on Wednesday, February 29, 2012 at 10:20 a.m. ET. The conference will be held at the Loews Hotel in Miami Beach, FL.
A live webcast and audio archive of the presentation will be available on the company's website at [ http://www.endo.com/ ]. Click on Investor Relations, and then the link to the Event and Presentation. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.
About Endo
Endo Pharmaceuticals Holdings is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals Holdings and its businesses American Medical Systems, HealthTronics and Qualitest Pharmaceuticals, please visit [ http://www.endo.com/ ].
SOURCE Endo Pharmaceuticals Holdings
[ Back to top ] RELATED LINKS
[ http://www.endo.com ]
